AGING CELL-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2153075, encodeId=03fd21530e538, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.3.7提交 2023.4.20审稿意见回来 major revision 2023.6.15 提交返修稿 2023.8.8 接收 想请教其他上岸的大佬们接收后杂志社移交给了wiley出版社，之后收到wiley的license等确认，并交了OA费，那么多久才会收到proof呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed Aug 16 19:13:02 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬，投稿AGING CELL直接就With Supervising Editor，状态七天了，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=591350, encodeId=6cee591350b9, content=请问显示under review约一周后后变成了with supervising editor正常么 艾特 188****3191(暂无昵称), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd861997355, createdName=aipanda皮, createdTime=Wed May 20 23:08:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248205, encodeId=0cdc12482058a, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见，已经两个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=12307963m39暂无昵称, createdTime=Fri Sep 09 21:19:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向：骨健康;蛋白质组 经验分享：投稿五天，现在处于With Supervising Editor状态，请问接收过的同行这个状态处于什么阶段，还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2136489, encodeId=3113213648953, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Aging cell 今年影响因子预测将大幅度下降，还值得投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed May 17 12:20:19 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0 偏重的研究方向：细胞衰老 经验分享：投了一篇，7张大图，纯细胞研究。一审一个半月，4个审稿人，一堆问题，还需要补实验。修改用了三个月，中间还申请了一次延迟，补了不少实验。修回去之后，二审两个礼拜，直接接收。总体很nice，是一本非常认真的期刊，审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿，晚上状态变成Under review，然后9月18日上午发现状态已经变成Awaiting EIC desicion，请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113817, encodeId=87d1211381e4d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Aging Cell很经典的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Thu Feb 09 16:41:49 CST 2023, time=2023-02-09, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2112490, encodeId=520b211249029, content=Decision in Process：编辑们正在系统中做出决定。该决定可能需要得到多个编辑的确认。当决定最终确定后，您将收到一封直接的电子邮件，其中包括负责这篇文章所有编辑的决定、编辑和/或审稿人的评论，以及进一步的说明。这里的和/或可能说明文章送审与否都会出现这一状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c18517184, createdName=ms7000001358858987, createdTime=Wed Feb 01 00:10:11 CST 2023, time=2023-02-01, status=1, ipAttribution=广东省)]

2023-08-16 ms9000001212726085 来自广东省

审稿速度:2.0 | 投稿命中率:50.0
经验分享：2023.3.7提交
2023.4.20审稿意见回来 major revision
2023.6.15 提交返修稿
2023.8.8 接收
想请教其他上岸的大佬们接收后杂志社移交给了wiley出版社，之后收到wiley的license等确认，并交了OA费，那么多久才会收到proof呢？

52 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2153075, encodeId=03fd21530e538, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.3.7提交 2023.4.20审稿意见回来 major revision 2023.6.15 提交返修稿 2023.8.8 接收 想请教其他上岸的大佬们接收后杂志社移交给了wiley出版社，之后收到wiley的license等确认，并交了OA费，那么多久才会收到proof呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed Aug 16 19:13:02 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬，投稿AGING CELL直接就With Supervising Editor，状态七天了，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=591350, encodeId=6cee591350b9, content=请问显示under review约一周后后变成了with supervising editor正常么 艾特 188****3191(暂无昵称), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd861997355, createdName=aipanda皮, createdTime=Wed May 20 23:08:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248205, encodeId=0cdc12482058a, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见，已经两个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=12307963m39暂无昵称, createdTime=Fri Sep 09 21:19:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向：骨健康;蛋白质组 经验分享：投稿五天，现在处于With Supervising Editor状态，请问接收过的同行这个状态处于什么阶段，还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2136489, encodeId=3113213648953, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Aging cell 今年影响因子预测将大幅度下降，还值得投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed May 17 12:20:19 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0 偏重的研究方向：细胞衰老 经验分享：投了一篇，7张大图，纯细胞研究。一审一个半月，4个审稿人，一堆问题，还需要补实验。修改用了三个月，中间还申请了一次延迟，补了不少实验。修回去之后，二审两个礼拜，直接接收。总体很nice，是一本非常认真的期刊，审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿，晚上状态变成Under review，然后9月18日上午发现状态已经变成Awaiting EIC desicion，请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113817, encodeId=87d1211381e4d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Aging Cell很经典的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Thu Feb 09 16:41:49 CST 2023, time=2023-02-09, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2112490, encodeId=520b211249029, content=Decision in Process：编辑们正在系统中做出决定。该决定可能需要得到多个编辑的确认。当决定最终确定后，您将收到一封直接的电子邮件，其中包括负责这篇文章所有编辑的决定、编辑和/或审稿人的评论，以及进一步的说明。这里的和/或可能说明文章送审与否都会出现这一状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c18517184, createdName=ms7000001358858987, createdTime=Wed Feb 01 00:10:11 CST 2023, time=2023-02-01, status=1, ipAttribution=广东省)]

2023-03-02 120b955dm62暂无昵称来自浙江省

各位大佬，投稿AGING CELL直接就With Supervising Editor，状态七天了，是不是要被拒了

135 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2153075, encodeId=03fd21530e538, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.3.7提交 2023.4.20审稿意见回来 major revision 2023.6.15 提交返修稿 2023.8.8 接收 想请教其他上岸的大佬们接收后杂志社移交给了wiley出版社，之后收到wiley的license等确认，并交了OA费，那么多久才会收到proof呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed Aug 16 19:13:02 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬，投稿AGING CELL直接就With Supervising Editor，状态七天了，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=591350, encodeId=6cee591350b9, content=请问显示under review约一周后后变成了with supervising editor正常么 艾特 188****3191(暂无昵称), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd861997355, createdName=aipanda皮, createdTime=Wed May 20 23:08:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248205, encodeId=0cdc12482058a, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见，已经两个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=12307963m39暂无昵称, createdTime=Fri Sep 09 21:19:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向：骨健康;蛋白质组 经验分享：投稿五天，现在处于With Supervising Editor状态，请问接收过的同行这个状态处于什么阶段，还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2136489, encodeId=3113213648953, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Aging cell 今年影响因子预测将大幅度下降，还值得投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed May 17 12:20:19 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0 偏重的研究方向：细胞衰老 经验分享：投了一篇，7张大图，纯细胞研究。一审一个半月，4个审稿人，一堆问题，还需要补实验。修改用了三个月，中间还申请了一次延迟，补了不少实验。修回去之后，二审两个礼拜，直接接收。总体很nice，是一本非常认真的期刊，审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿，晚上状态变成Under review，然后9月18日上午发现状态已经变成Awaiting EIC desicion，请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113817, encodeId=87d1211381e4d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Aging Cell很经典的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Thu Feb 09 16:41:49 CST 2023, time=2023-02-09, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2112490, encodeId=520b211249029, content=Decision in Process：编辑们正在系统中做出决定。该决定可能需要得到多个编辑的确认。当决定最终确定后，您将收到一封直接的电子邮件，其中包括负责这篇文章所有编辑的决定、编辑和/或审稿人的评论，以及进一步的说明。这里的和/或可能说明文章送审与否都会出现这一状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c18517184, createdName=ms7000001358858987, createdTime=Wed Feb 01 00:10:11 CST 2023, time=2023-02-01, status=1, ipAttribution=广东省)]

2020-05-20 aipanda皮

请问显示under review约一周后后变成了with supervising editor正常么
艾特 188****3191(暂无昵称)

200 23

展开23条回复

[GetPortalCommentsPageByObjectIdResponse(id=2153075, encodeId=03fd21530e538, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.3.7提交 2023.4.20审稿意见回来 major revision 2023.6.15 提交返修稿 2023.8.8 接收 想请教其他上岸的大佬们接收后杂志社移交给了wiley出版社，之后收到wiley的license等确认，并交了OA费，那么多久才会收到proof呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed Aug 16 19:13:02 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬，投稿AGING CELL直接就With Supervising Editor，状态七天了，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=591350, encodeId=6cee591350b9, content=请问显示under review约一周后后变成了with supervising editor正常么 艾特 188****3191(暂无昵称), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd861997355, createdName=aipanda皮, createdTime=Wed May 20 23:08:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248205, encodeId=0cdc12482058a, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见，已经两个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=12307963m39暂无昵称, createdTime=Fri Sep 09 21:19:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向：骨健康;蛋白质组 经验分享：投稿五天，现在处于With Supervising Editor状态，请问接收过的同行这个状态处于什么阶段，还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2136489, encodeId=3113213648953, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Aging cell 今年影响因子预测将大幅度下降，还值得投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed May 17 12:20:19 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0 偏重的研究方向：细胞衰老 经验分享：投了一篇，7张大图，纯细胞研究。一审一个半月，4个审稿人，一堆问题，还需要补实验。修改用了三个月，中间还申请了一次延迟，补了不少实验。修回去之后，二审两个礼拜，直接接收。总体很nice，是一本非常认真的期刊，审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿，晚上状态变成Under review，然后9月18日上午发现状态已经变成Awaiting EIC desicion，请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113817, encodeId=87d1211381e4d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Aging Cell很经典的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Thu Feb 09 16:41:49 CST 2023, time=2023-02-09, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2112490, encodeId=520b211249029, content=Decision in Process：编辑们正在系统中做出决定。该决定可能需要得到多个编辑的确认。当决定最终确定后，您将收到一封直接的电子邮件，其中包括负责这篇文章所有编辑的决定、编辑和/或审稿人的评论，以及进一步的说明。这里的和/或可能说明文章送审与否都会出现这一状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c18517184, createdName=ms7000001358858987, createdTime=Wed Feb 01 00:10:11 CST 2023, time=2023-02-01, status=1, ipAttribution=广东省)]

2022-09-09 12307963m39暂无昵称

7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见，已经两个多月了

115 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2153075, encodeId=03fd21530e538, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.3.7提交 2023.4.20审稿意见回来 major revision 2023.6.15 提交返修稿 2023.8.8 接收 想请教其他上岸的大佬们接收后杂志社移交给了wiley出版社，之后收到wiley的license等确认，并交了OA费，那么多久才会收到proof呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed Aug 16 19:13:02 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬，投稿AGING CELL直接就With Supervising Editor，状态七天了，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=591350, encodeId=6cee591350b9, content=请问显示under review约一周后后变成了with supervising editor正常么 艾特 188****3191(暂无昵称), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd861997355, createdName=aipanda皮, createdTime=Wed May 20 23:08:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248205, encodeId=0cdc12482058a, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见，已经两个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=12307963m39暂无昵称, createdTime=Fri Sep 09 21:19:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向：骨健康;蛋白质组 经验分享：投稿五天，现在处于With Supervising Editor状态，请问接收过的同行这个状态处于什么阶段，还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2136489, encodeId=3113213648953, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Aging cell 今年影响因子预测将大幅度下降，还值得投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed May 17 12:20:19 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0 偏重的研究方向：细胞衰老 经验分享：投了一篇，7张大图，纯细胞研究。一审一个半月，4个审稿人，一堆问题，还需要补实验。修改用了三个月，中间还申请了一次延迟，补了不少实验。修回去之后，二审两个礼拜，直接接收。总体很nice，是一本非常认真的期刊，审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿，晚上状态变成Under review，然后9月18日上午发现状态已经变成Awaiting EIC desicion，请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113817, encodeId=87d1211381e4d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Aging Cell很经典的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Thu Feb 09 16:41:49 CST 2023, time=2023-02-09, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2112490, encodeId=520b211249029, content=Decision in Process：编辑们正在系统中做出决定。该决定可能需要得到多个编辑的确认。当决定最终确定后，您将收到一封直接的电子邮件，其中包括负责这篇文章所有编辑的决定、编辑和/或审稿人的评论，以及进一步的说明。这里的和/或可能说明文章送审与否都会出现这一状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c18517184, createdName=ms7000001358858987, createdTime=Wed Feb 01 00:10:11 CST 2023, time=2023-02-01, status=1, ipAttribution=广东省)]

2023-05-29 湖来自广东省

偏重的研究方向：骨健康;蛋白质组
经验分享：投稿五天，现在处于With Supervising Editor状态，请问接收过的同行这个状态处于什么阶段，还有多久Under Review

54 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2153075, encodeId=03fd21530e538, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.3.7提交 2023.4.20审稿意见回来 major revision 2023.6.15 提交返修稿 2023.8.8 接收 想请教其他上岸的大佬们接收后杂志社移交给了wiley出版社，之后收到wiley的license等确认，并交了OA费，那么多久才会收到proof呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed Aug 16 19:13:02 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬，投稿AGING CELL直接就With Supervising Editor，状态七天了，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=591350, encodeId=6cee591350b9, content=请问显示under review约一周后后变成了with supervising editor正常么 艾特 188****3191(暂无昵称), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd861997355, createdName=aipanda皮, createdTime=Wed May 20 23:08:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248205, encodeId=0cdc12482058a, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见，已经两个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=12307963m39暂无昵称, createdTime=Fri Sep 09 21:19:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向：骨健康;蛋白质组 经验分享：投稿五天，现在处于With Supervising Editor状态，请问接收过的同行这个状态处于什么阶段，还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2136489, encodeId=3113213648953, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Aging cell 今年影响因子预测将大幅度下降，还值得投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed May 17 12:20:19 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0 偏重的研究方向：细胞衰老 经验分享：投了一篇，7张大图，纯细胞研究。一审一个半月，4个审稿人，一堆问题，还需要补实验。修改用了三个月，中间还申请了一次延迟，补了不少实验。修回去之后，二审两个礼拜，直接接收。总体很nice，是一本非常认真的期刊，审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿，晚上状态变成Under review，然后9月18日上午发现状态已经变成Awaiting EIC desicion，请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113817, encodeId=87d1211381e4d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Aging Cell很经典的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Thu Feb 09 16:41:49 CST 2023, time=2023-02-09, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2112490, encodeId=520b211249029, content=Decision in Process：编辑们正在系统中做出决定。该决定可能需要得到多个编辑的确认。当决定最终确定后，您将收到一封直接的电子邮件，其中包括负责这篇文章所有编辑的决定、编辑和/或审稿人的评论，以及进一步的说明。这里的和/或可能说明文章送审与否都会出现这一状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c18517184, createdName=ms7000001358858987, createdTime=Wed Feb 01 00:10:11 CST 2023, time=2023-02-01, status=1, ipAttribution=广东省)]

2023-05-17 ms9000001212726085 来自广东省

审稿速度:2.0 | 投稿命中率:50.0
经验分享：Aging cell 今年影响因子预测将大幅度下降，还值得投吗

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2153075, encodeId=03fd21530e538, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.3.7提交 2023.4.20审稿意见回来 major revision 2023.6.15 提交返修稿 2023.8.8 接收 想请教其他上岸的大佬们接收后杂志社移交给了wiley出版社，之后收到wiley的license等确认，并交了OA费，那么多久才会收到proof呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed Aug 16 19:13:02 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬，投稿AGING CELL直接就With Supervising Editor，状态七天了，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=591350, encodeId=6cee591350b9, content=请问显示under review约一周后后变成了with supervising editor正常么 艾特 188****3191(暂无昵称), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd861997355, createdName=aipanda皮, createdTime=Wed May 20 23:08:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248205, encodeId=0cdc12482058a, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见，已经两个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=12307963m39暂无昵称, createdTime=Fri Sep 09 21:19:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向：骨健康;蛋白质组 经验分享：投稿五天，现在处于With Supervising Editor状态，请问接收过的同行这个状态处于什么阶段，还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2136489, encodeId=3113213648953, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Aging cell 今年影响因子预测将大幅度下降，还值得投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed May 17 12:20:19 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0 偏重的研究方向：细胞衰老 经验分享：投了一篇，7张大图，纯细胞研究。一审一个半月，4个审稿人，一堆问题，还需要补实验。修改用了三个月，中间还申请了一次延迟，补了不少实验。修回去之后，二审两个礼拜，直接接收。总体很nice，是一本非常认真的期刊，审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿，晚上状态变成Under review，然后9月18日上午发现状态已经变成Awaiting EIC desicion，请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113817, encodeId=87d1211381e4d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Aging Cell很经典的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Thu Feb 09 16:41:49 CST 2023, time=2023-02-09, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2112490, encodeId=520b211249029, content=Decision in Process：编辑们正在系统中做出决定。该决定可能需要得到多个编辑的确认。当决定最终确定后，您将收到一封直接的电子邮件，其中包括负责这篇文章所有编辑的决定、编辑和/或审稿人的评论，以及进一步的说明。这里的和/或可能说明文章送审与否都会出现这一状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c18517184, createdName=ms7000001358858987, createdTime=Wed Feb 01 00:10:11 CST 2023, time=2023-02-01, status=1, ipAttribution=广东省)]

2021-06-01 胡同串子羊

投稿命中率:25.0
偏重的研究方向：细胞衰老
经验分享：投了一篇，7张大图，纯细胞研究。一审一个半月，4个审稿人，一堆问题，还需要补实验。修改用了三个月，中间还申请了一次延迟，补了不少实验。修回去之后，二审两个礼拜，直接接收。总体很nice，是一本非常认真的期刊，审稿人水平很高。

134 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=2153075, encodeId=03fd21530e538, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.3.7提交 2023.4.20审稿意见回来 major revision 2023.6.15 提交返修稿 2023.8.8 接收 想请教其他上岸的大佬们接收后杂志社移交给了wiley出版社，之后收到wiley的license等确认，并交了OA费，那么多久才会收到proof呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed Aug 16 19:13:02 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬，投稿AGING CELL直接就With Supervising Editor，状态七天了，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=591350, encodeId=6cee591350b9, content=请问显示under review约一周后后变成了with supervising editor正常么 艾特 188****3191(暂无昵称), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd861997355, createdName=aipanda皮, createdTime=Wed May 20 23:08:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248205, encodeId=0cdc12482058a, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见，已经两个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=12307963m39暂无昵称, createdTime=Fri Sep 09 21:19:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向：骨健康;蛋白质组 经验分享：投稿五天，现在处于With Supervising Editor状态，请问接收过的同行这个状态处于什么阶段，还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2136489, encodeId=3113213648953, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Aging cell 今年影响因子预测将大幅度下降，还值得投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed May 17 12:20:19 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0 偏重的研究方向：细胞衰老 经验分享：投了一篇，7张大图，纯细胞研究。一审一个半月，4个审稿人，一堆问题，还需要补实验。修改用了三个月，中间还申请了一次延迟，补了不少实验。修回去之后，二审两个礼拜，直接接收。总体很nice，是一本非常认真的期刊，审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿，晚上状态变成Under review，然后9月18日上午发现状态已经变成Awaiting EIC desicion，请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113817, encodeId=87d1211381e4d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Aging Cell很经典的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Thu Feb 09 16:41:49 CST 2023, time=2023-02-09, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2112490, encodeId=520b211249029, content=Decision in Process：编辑们正在系统中做出决定。该决定可能需要得到多个编辑的确认。当决定最终确定后，您将收到一封直接的电子邮件，其中包括负责这篇文章所有编辑的决定、编辑和/或审稿人的评论，以及进一步的说明。这里的和/或可能说明文章送审与否都会出现这一状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c18517184, createdName=ms7000001358858987, createdTime=Wed Feb 01 00:10:11 CST 2023, time=2023-02-01, status=1, ipAttribution=广东省)]

2022-09-19 ms7000000167420570

9月15日下午投的稿，晚上状态变成Under review，然后9月18日上午发现状态已经变成Awaiting EIC desicion，请问是要被拒了吗

108 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2153075, encodeId=03fd21530e538, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.3.7提交 2023.4.20审稿意见回来 major revision 2023.6.15 提交返修稿 2023.8.8 接收 想请教其他上岸的大佬们接收后杂志社移交给了wiley出版社，之后收到wiley的license等确认，并交了OA费，那么多久才会收到proof呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed Aug 16 19:13:02 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬，投稿AGING CELL直接就With Supervising Editor，状态七天了，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=591350, encodeId=6cee591350b9, content=请问显示under review约一周后后变成了with supervising editor正常么 艾特 188****3191(暂无昵称), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd861997355, createdName=aipanda皮, createdTime=Wed May 20 23:08:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248205, encodeId=0cdc12482058a, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见，已经两个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=12307963m39暂无昵称, createdTime=Fri Sep 09 21:19:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向：骨健康;蛋白质组 经验分享：投稿五天，现在处于With Supervising Editor状态，请问接收过的同行这个状态处于什么阶段，还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2136489, encodeId=3113213648953, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Aging cell 今年影响因子预测将大幅度下降，还值得投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed May 17 12:20:19 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0 偏重的研究方向：细胞衰老 经验分享：投了一篇，7张大图，纯细胞研究。一审一个半月，4个审稿人，一堆问题，还需要补实验。修改用了三个月，中间还申请了一次延迟，补了不少实验。修回去之后，二审两个礼拜，直接接收。总体很nice，是一本非常认真的期刊，审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿，晚上状态变成Under review，然后9月18日上午发现状态已经变成Awaiting EIC desicion，请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113817, encodeId=87d1211381e4d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Aging Cell很经典的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Thu Feb 09 16:41:49 CST 2023, time=2023-02-09, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2112490, encodeId=520b211249029, content=Decision in Process：编辑们正在系统中做出决定。该决定可能需要得到多个编辑的确认。当决定最终确定后，您将收到一封直接的电子邮件，其中包括负责这篇文章所有编辑的决定、编辑和/或审稿人的评论，以及进一步的说明。这里的和/或可能说明文章送审与否都会出现这一状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c18517184, createdName=ms7000001358858987, createdTime=Wed Feb 01 00:10:11 CST 2023, time=2023-02-01, status=1, ipAttribution=广东省)]

2023-02-09 snowboy 来自云南省

审稿速度:2.0 | 投稿命中率:25.0
经验分享：Aging Cell很经典的期刊

53 0

[GetPortalCommentsPageByObjectIdResponse(id=2153075, encodeId=03fd21530e538, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.3.7提交 2023.4.20审稿意见回来 major revision 2023.6.15 提交返修稿 2023.8.8 接收 想请教其他上岸的大佬们接收后杂志社移交给了wiley出版社，之后收到wiley的license等确认，并交了OA费，那么多久才会收到proof呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed Aug 16 19:13:02 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬，投稿AGING CELL直接就With Supervising Editor，状态七天了，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=591350, encodeId=6cee591350b9, content=请问显示under review约一周后后变成了with supervising editor正常么 艾特 188****3191(暂无昵称), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd861997355, createdName=aipanda皮, createdTime=Wed May 20 23:08:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248205, encodeId=0cdc12482058a, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见，已经两个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=12307963m39暂无昵称, createdTime=Fri Sep 09 21:19:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向：骨健康;蛋白质组 经验分享：投稿五天，现在处于With Supervising Editor状态，请问接收过的同行这个状态处于什么阶段，还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2136489, encodeId=3113213648953, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Aging cell 今年影响因子预测将大幅度下降，还值得投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed May 17 12:20:19 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0 偏重的研究方向：细胞衰老 经验分享：投了一篇，7张大图，纯细胞研究。一审一个半月，4个审稿人，一堆问题，还需要补实验。修改用了三个月，中间还申请了一次延迟，补了不少实验。修回去之后，二审两个礼拜，直接接收。总体很nice，是一本非常认真的期刊，审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿，晚上状态变成Under review，然后9月18日上午发现状态已经变成Awaiting EIC desicion，请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113817, encodeId=87d1211381e4d, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Aging Cell很经典的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b8e10256, createdName=snowboy, createdTime=Thu Feb 09 16:41:49 CST 2023, time=2023-02-09, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2112490, encodeId=520b211249029, content=Decision in Process：编辑们正在系统中做出决定。该决定可能需要得到多个编辑的确认。当决定最终确定后，您将收到一封直接的电子邮件，其中包括负责这篇文章所有编辑的决定、编辑和/或审稿人的评论，以及进一步的说明。这里的和/或可能说明文章送审与否都会出现这一状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c18517184, createdName=ms7000001358858987, createdTime=Wed Feb 01 00:10:11 CST 2023, time=2023-02-01, status=1, ipAttribution=广东省)]

2023-02-01 ms7000001358858987 来自广东省

Decision in Process：编辑们正在系统中做出决定。该决定可能需要得到多个编辑的确认。当决定最终确定后，您将收到一封直接的电子邮件，其中包括负责这篇文章所有编辑的决定、编辑和/或审稿人的评论，以及进一步的说明。这里的和/或可能说明文章送审与否都会出现这一状态

55 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务